Effects of Thiazolidinediones on Stroke Recovery: A Case-Matched Controlled Study
- 8 September 2006
- journal article
- Published by Springer Science and Business Media LLC in Neurochemical Research
- Vol. 32 (4), 635-638
- https://doi.org/10.1007/s11064-006-9138-3
Abstract
Anti-inflammatory therapy decreases infarct size and enhances stroke recovery. Thiazolidinedione peroxisome proliferator-activated receptor (PPAR)gamma agonists have potent anti-inflammatory and insulin-sensitizing anti-diabetic actions. Thirty stroke patients with type 2 diabetes admitted for acute inpatient stroke rehabilitation receiving pioglitazone or rosiglitazone were matched for age, sex, initial FIMTM score and interval post-stroke with 30 stroke patients with type 2 diabetes not receiving thiazolidinediones. Relevant outcome variables were compared for both groups. The thiazolidinedione treated group showed significantly greater mean improvement in FIMTM score compared to control group (25.6 ± 10.2 SD vs. 19.8 ± 10.5, respectively, P = 0.015). There was no significant difference in length of rehabilitation hospital stay (24.2 ± 7.6 vs. 25.1 ± 7.4 days, P = 0.657) or final discharge destination (home/institution, 19/11 versus 17/13, P = 0.792). Use of thiazolidinediones was associated with enhanced functional recovery in stroke patients with type 2 diabetes.Keywords
This publication has 9 references indexed in Scilit:
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemiaNeuroscience, 2005
- Peroxisome Proliferator-Activated Receptor γ: Implications for Cardiovascular DiseaseHypertension, 2004
- Antiinflammatory properties of PPARgamma agonists following ischemiaDrug News & Perspectives, 2004
- Novel actions of thiazolidinediones on vascular function and exercise capacityThe American Journal of Medicine, 2003
- Current and Future Therapeutic Strategies to Target Inflammation in StrokeCurrent Drug Targets - Inflammation & Allergy, 2002
- The Role of Hyperglycemia in Acute StrokeArchives of Neurology, 2001
- Cerebral ischemia and inflammationCurrent Opinion in Neurology, 2001
- Pathobiology of ischaemic stroke: an integrated viewTrends in Neurosciences, 1999